Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Portohepatic fusion mimics biliary aplasia.

BMJ case reports·2025
Same author

Primary Ovarian Non-Gestational Placental Site Trophoblastic Tumor in a Pediatric Patient: A Case Report and Review of the Literature.

Pediatric blood & cancer·2025
Same author

Rapidly recurrent trichobezoar management.

BMJ case reports·2024
Same author

An unusual case of metastatic trophoblastic neoplasm presenting with diffuse cystic lung disease and pulmonary artery pseudoaneurysms in a teenager.

Pediatric pulmonology·2024
Same author

Ovarian non-gestational placental site trophoblastic tumor with lung metastasis: further evidence for a distinct category of trophoblastic neoplasm.

Diagnostic pathology·2024
Same author

The Problematic PET: Using CT Albumin Tracer to Resect Suspicious Lymph Nodes Found on PET Scan in Pediatric Oncology Patients.

Journal of pediatric surgery·2023

Related Experiment Videos

Post-ERCP pancreatitis in pediatric patients.

Corey W Iqbal1, Todd H Baron, Christopher R Moir

  • 1Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.

Journal of Pediatric Gastroenterology and Nutrition
|December 25, 2009
PubMed
Summary
This summary is machine-generated.

Post-ERCP pancreatitis is uncommon, affecting 2.5% of patients without chronic pancreatitis. Therapeutic procedures and chronic pancreatitis increase the risk of this complication.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Pediatric Endoscopy

Background:

  • Pancreatitis is a recognized complication following endoscopic retrograde cholangiopancreatography (ERCP).
  • Assessing the incidence and severity of ERCP-associated pancreatitis is crucial for patient safety.

Purpose of the Study:

  • To determine the prevalence and severity of pancreatitis after ERCP in pediatric patients.
  • To identify risk factors associated with post-ERCP pancreatitis.

Main Methods:

  • Retrospective review of pediatric patients (<18 years) who underwent ERCP.
  • Utilized the 1991 consensus statement criteria for diagnosing post-ERCP pancreatitis.
  • Analyzed risk factors, including chronic pancreatitis and pancreatic duct stenting.

Main Results:

  • Overall prevalence of post-ERCP pancreatitis was 2.5% in patients without chronic pancreatitis (7/276 ERCPs).
  • Prevalence was higher (14.9%) in patients with chronic pancreatitis (10/67 ERCPs).
  • Diagnostic ERCPs were associated with a lower risk of pancreatitis (P<0.01), while pancreatic duct stenting was a risk factor in chronic pancreatitis patients (P=0.02).

Conclusions:

  • Post-ERCP pancreatitis prevalence is low (2.5%) when excluding patients with chronic pancreatitis.
  • Therapeutic ERCP procedures and the presence of chronic pancreatitis are identified as risk factors for developing pancreatitis.